- Home
- ORGO vs DNUT Comparison
ORGO vs DNUT Comparison
Compare ORGO & DNUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- DNUT
- Stock Information
- Founded
- ORGO 1985
- DNUT 1937
- Country
- ORGO United States
- DNUT United States
- Employees
- ORGO N/A
- DNUT N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- DNUT Food Chains
- Sector
- ORGO Health Care
- DNUT Consumer Staples
- Exchange
- ORGO Nasdaq
- DNUT Nasdaq
- Market Cap
- ORGO 620.3M
- DNUT 578.7M
- IPO Year
- ORGO N/A
- DNUT 2021
- Fundamental
- Price
- ORGO $4.08
- DNUT $3.44
- Analyst Decision
- ORGO Buy
- DNUT Buy
- Analyst Count
- ORGO 3
- DNUT 6
- Target Price
- ORGO $7.33
- DNUT $6.22
- AVG Volume (30 Days)
- ORGO 800.7K
- DNUT 5.0M
- Earning Date
- ORGO 11-06-2025
- DNUT 11-06-2025
- Dividend Yield
- ORGO N/A
- DNUT 2.87%
- EPS Growth
- ORGO N/A
- DNUT N/A
- EPS
- ORGO N/A
- DNUT N/A
- Revenue
- ORGO $429,531,000.00
- DNUT $1,538,841,000.00
- Revenue This Year
- ORGO $2.51
- DNUT N/A
- Revenue Next Year
- ORGO $25.45
- DNUT $0.71
- P/E Ratio
- ORGO N/A
- DNUT N/A
- Revenue Growth
- ORGO N/A
- DNUT N/A
- 52 Week Low
- ORGO $2.61
- DNUT $2.50
- 52 Week High
- ORGO $6.71
- DNUT $12.68
- Technical
- Relative Strength Index (RSI)
- ORGO 37.32
- DNUT 47.62
- Support Level
- ORGO $4.12
- DNUT $3.65
- Resistance Level
- ORGO $4.40
- DNUT $3.95
- Average True Range (ATR)
- ORGO 0.24
- DNUT 0.25
- MACD
- ORGO -0.06
- DNUT 0.02
- Stochastic Oscillator
- ORGO 11.96
- DNUT 35.94
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About DNUT Krispy Kreme Inc.
Krispy Kreme Inc is a sweet treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations across the globe. It derives maximum revenue from the U.S. segment.